Myelodysplasia is a group of disorders of the hematopoietic system, in which there is a disturbance in the structure and function of the bone marrow. This leads to the body's inability to produce a sufficient number of healthy blood cells.
Symptoms of myelodysplasia may include anemia, increased fatigue, weakness, frequent infections, increased bleeding, enlarged lymph nodes, and spleen.
The causes of myelodysplasia may be related to genetic changes, environmental factors, as well as exposure to chemical substances such as mercury, benzene, and others.
The diagnosis of myelodysplasia includes blood and bone marrow analysis, biochemical studies, cytogenetic analysis, and others.
Treatment of myelodysplasia may include bone marrow transplantation, chemotherapy, immunotherapy, and supportive therapy.
Prevention of myelodysplasia involves minimizing contact with potentially hazardous chemical substances, maintaining a healthy lifestyle, and regular medical check-ups.
Treatment and observation of patients with myelodysplasia are carried out by hematologists and oncologists.
Note: This material is provided for informational purposes only and is not medical advice.